Lombard Odier Asset Management (Switzerland) Sa Immuno Gen, Inc. Transaction History

Lombard Odier Asset Management (Switzerland) Sa

$1.14 Billion
Q3 2024

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 15, 2023	SELL	$3.67 - $4.92 $537,133 - $720,081	-146,358 Reduced 15.63%	790,143 $3.03 Million
Q3 2022 Nov 14, 2022	SELL	$4.48 - $6.47 $305,200 - $440,768	-68,125 Reduced 6.78%	936,501 $4.48 Million
Q2 2022 Aug 15, 2022	SELL	$3.15 - $5.76 $4 Million - $7.32 Million	-1,270,783 Reduced 55.85%	1,004,626 $4.52 Million
Q1 2022 May 16, 2022	SELL	$4.26 - $7.48 $4.98 Million - $8.74 Million	-1,168,115 Reduced 33.92%	2,275,409 $10.8 Million
Q4 2021 Feb 14, 2022	BUY	$4.75 - $7.5 $2.04 Million - $3.23 Million	430,057 Added 14.27%	3,443,524 $25.6 Million
Q3 2021 Nov 12, 2021	BUY	$5.02 - $6.59 $1.8 Million - $2.36 Million	358,629 Added 13.51%	3,013,467 $17.1 Million
Q2 2021 Aug 13, 2021	BUY	$5.79 - $8.6 $4.66 Million - $6.92 Million	805,066 Added 43.52%	2,654,838 $17.5 Million
Q1 2021 May 17, 2021	BUY	$6.5 - $10.53 $12 Million - $19.5 Million	1,849,772 New	1,849,772 $15 Million

Others Institutions Holding IMGN

# of Institutions

Shares Held

1.41M

Call Options Held

Put Options Held

View Full List

About ImmunoGen, Inc.

Ticker IMGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 220,712,992
Description
ImmunoGen, Inc., a clinical-stage biotechnology company, develops antibody-drug conjugate (ADC) therapies to treat cancer. The company's product candidates include mirvetuximab soravtansine, an ADC targeting folate-receptor alpha (FRa), which is in Phase III clinical trial for the treatment of platinum-resistant ovarian cancer; and Pivekimab sun...

More about IMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lombard Odier Asset Management (Switzerland) Sa, based on Form 13F filings with the SEC.

News

Stay updated on Lombard Odier Asset Management (Switzerland) Sa with notifications on news.

Account